News & Events

Boosting the efficiency of single-cell RNA-sequencing helps reveal subtle differences between healthy and dysfunctional cells. Sequencing RNA from individual cells can reveal a great deal of information about what those cells are doing in the body. MIT researchers have now greatly boosted the amount of information gleaned from each of…

Using these new particles, researchers, including a member of the IMES faculty, could develop treatments for heart disease and other conditions. Using specialized nanoparticles, MIT engineers have developed a way to turn off specific genes in cells of the bone marrow, which play an important role in producing blood cells….

Michael Birnbaum, Anders Hansen, and Tami Lieberman receive NIH Director’s New Innovator Awards from the NIH Common Fund’s High-Risk, High-Reward Research program. Three MIT faculty members have been chosen to receive the New Innovators Award from the National Institutes of Health (NIH) as part of its High-Risk, High-Reward Research program….

With computer models and lab experiments, researchers, including a member of the IMES faculty, are working on a strategy for vaccines that could protect against any influenza virus. Each year, the flu vaccine has to be redesigned to account for mutations that the virus accumulates, and even then, the vaccine…

InfiniteMD, co-founded by an HST alumnus, virtually connects patients with leading medical specialists to give advice on treatment plans, diagnoses, and more. Earlier this year, a little girl was struggling with a neurological condition that caused her to have 20 to 30 seizures a day. Her parents were working with…

A member of the IMES affiliate faculty is announced as award’s first recipient for work in cancer diagnosis and drug synthesis. For more than 100 years Nobel Prizes have been given out annually to recognize breakthrough achievements in chemistry, literature, medicine, peace, and physics. As these disciplines undoubtedly continue to…

MIT researchers have always been drawn to urgent, life-or-death problems. The pandemic is keeping them busy, including two affiliated with IMES. This story was originally published in MIT Technology Review: https://www.technologyreview.com/2020/08/18/1006213/tackling-covid/ As covid-19 spread across the globe, killing hundreds of thousands and wreaking economic havoc, the MIT community took on…

New book for the general public by the founding director of IMES explains how novel viruses such as SARS-Cov-2 emerge and how we can fight them. Since the novel coronavirus SARS-Cov-2 emerged late last year, it has been virtually impossible to consume any news without encountering stories about the virus…

The company Health at Scale, co-founded by two HST alumni and an MIT professor, uses machine learning to improve outcomes for individual patients. The health care system today largely focuses on helping people after they have problems. When they do receive treatment, it’s based on what has worked best on…

Transitioning to graduate or medical school is a challenge ­– doing so during a pandemic, even more so. This year’s incoming Harvard-MIT Program in Health Sciences and Technology (HST) class will be facing that challenge, as many will be among the Harvard and MIT students taking classes remotely to begin…